Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Ceapro Inc V.CZO

Ceapro Inc. is a Canada-based biotechnology company. The Company is involved in the development of extraction technology and the application of this technology to the production of extracts and active ingredients from oats and other renewable plant resources. Its primary business activities relate to the development and commercialization of natural products for personal care, cosmetic, human, and animal health industries using technology, natural, renewable resources, and developing products, technologies, and delivery systems. The Company's products include a commercial line of natural active ingredients, including beta glucan, avenanthramides (colloidal oat extract), oat powder, oat oil, oat peptides, and lupin peptides, a commercial line of natural anti-aging skincare products, utilizing active ingredients, including beta glucan and avenanthramides and veterinary therapeutic products, including an oat shampoo, an ear cleanser, and a dermal complex/conditioner.


TSXV:CZO - Post by User

Comment by Ciaoon Feb 08, 2024 9:18am
82 Views
Post# 35869500

RE:RE:Table has slipped

RE:RE:Table has slipped
ZoranSto wrote: Thanks for the information. A couple of questions:

Are there any other suppliers that can replace Ceapros product?
Did they have that much inventory that they could avoid buying stock from Ceapro?
Could they be using less of Ceapro product in there manufacturing process?

These are the only things that come to mind as to why there is such a drop in sales to Kenvue.

Regardless ceapro should have grown their business instead of relying on one large customer.



When you have an unmotivated, disengaged CEO, who is not accountable, and is content to sit on the laurels of J&J's success with AVEENO, I guess we shouldn't expect much.

"Regardless ceapro should have grown their business instead of relying on one large customer."
<< Previous
Bullboard Posts
Next >>